Inhaled Treatment for Bronchopulmonary Dysplasia

NCT04619602 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped FDA hold

Conditions

Bronchopulmonary Dysplasia

Interventions

DRUG: GSNO

Sponsor

University Hospitals Cleveland Medical Center